Skip to content
10-K

Annual Report

Editas Medicine, Inc. EDIT

0001650664-26-000017

← back to feed
Filed
Mar 9, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 27, 2026 97.87M sh
Shares Diluted FY 2025 · Dec 31, 2025 88.75M sh
Shares Diluted FY 2025 · Dec 31, 2024 82.34M sh
Capex FY 2025 · Dec 31, 2025 $607K
Capex FY 2025 · Dec 31, 2024 $8.83M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$165.24M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$210.28M
Long Term Debt FY 2025 · Dec 31, 2025 $53.61M
Long Term Debt FY 2025 · Dec 31, 2024 $52.43M
Short Term Debt FY 2025 · Dec 31, 2025 $5M
Short Term Debt FY 2025 · Dec 31, 2024 $5M
Cash And Equivalents FY 2025 · Dec 31, 2025 $146.65M
Cash And Equivalents FY 2025 · Dec 31, 2024 $131.54M
Stockholders Equity FY 2025 · Dec 31, 2025 $27.29M
Stockholders Equity FY 2025 · Dec 31, 2024 $134.27M
Stockholders Equity FY 2025 · Dec 31, 2023 $349.1M
Current Liabilities FY 2025 · Dec 31, 2025 $46.25M
Current Liabilities FY 2025 · Dec 31, 2024 $77.23M
Total Liabilities FY 2025 · Dec 31, 2025 $159.25M
Total Liabilities FY 2025 · Dec 31, 2024 $207.32M
Current Assets FY 2025 · Dec 31, 2025 $163.9M
Current Assets FY 2025 · Dec 31, 2024 $289.32M
Total Assets FY 2025 · Dec 31, 2025 $186.53M
Total Assets FY 2025 · Dec 31, 2024 $341.59M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.80
Eps Diluted FY 2025 · Dec 31, 2024 −$2.88
Eps Basic FY 2025 · Dec 31, 2025 −$1.80
Eps Basic FY 2025 · Dec 31, 2024 −$2.88
Sga Expense FY 2025 · Dec 31, 2025 $49.9M
Sga Expense FY 2025 · Dec 31, 2024 $71.99M
Rd Expense FY 2025 · Dec 31, 2025 $89.95M
Rd Expense FY 2025 · Dec 31, 2024 $199.25M
Net Income FY 2025 · Dec 31, 2025 −$160.06M
Net Income FY 2025 · Dec 31, 2024 −$237.09M
Operating Income FY 2025 · Dec 31, 2025 −$160.01M
Operating Income FY 2025 · Dec 31, 2024 −$251.15M
Revenue FY 2025 · Dec 31, 2025 $40.52M
Revenue FY 2025 · Dec 31, 2024 $32.31M